The current model of medicine, which is based on the treatment of diseases via a “one-size-fits-all” approach, is outdated, inefficient, costly, and in some cases harmful. New technological and scientific discoveries have demonstrated that diseases are extremely heterogeneous and vary from one patient to another.

Institutional policies and implicit biases have resulted in neglect at the point of care, higher rates of insurance loss, and a divestment of resources from diseases primarily impacting Black people. These inequities are evident in the past and present state of care in the US for sickle cell disease (SCD), an inherited blood disorder prevalent in those with sub-Saharan African or other malaria-endemic regional ancestry.

Despite advances in the drug development process, the price of drugs in the United States continues to rise.

Until the 1900s, infectious diseases were responsible for the highest number of deaths worldwide.

“We have four bankruptcies and three companies on the ropes, and not many will invest in this space”

Birth control refers to the use of devices, medications, surgical procedures, and sexual behaviors to prevent pregnancies.

Success in the biopharmaceuticals industry relies on the continuous development of novel drug molecules.

With recent technological advances, 3D printing has gained increasing acceptance in industries as varied as architecture, automotive and aerospace.